Fully Funded PhD Scholarship in Cancer Biology: Nanobody Innovations Targeting Gynaecological Cancers at Swansea University 2026 in UK

Are you passionate about advancing cancer research and looking for a fully funded PhD scholarship in cancer biology UK that combines cutting-edge science with international collaboration? Imagine contributing to next-generation therapies that could transform treatment for ovarian and other gynaecological cancers. Swansea University, in partnership with the Houston Methodist Research Institute in Texas, is offering an exceptional opportunity through its Strategic Partnership Research Scholarship (SUSPRS). This fully funded international PhD studentship centres on nanobody-based precision targeting tools for theranostic applications in gynaecological cancers (RS982).

If you hold a strong academic background in biomedical sciences, molecular biology, or a related field and want to work at the intersection of translational oncology, protein engineering, and cancer immunology, this programme deserves your attention. With a closing date of 17 August 2026, now is the time to prepare a competitive application for a start in October 2026 or January 2027.

Scholarship Summary

Host Country: UK
Host University: Swansea University
Scholarship Type: PhD Scholarships
Eligible Countries: All Countries
Scholarship Benefits: Full tuition fee, Living stipend, etc.

This collaborative PhD is aligned with Biomedical Sciences within the Faculty of Medicine, Health and Life Science at Swansea University. It forms part of the ninth cohort of the Swansea University Strategic Partnership Research Scholarships and provides unique dual-location training spanning the UK and one of the world’s largest medical centres.

Why This Fully Funded PhD in Cancer Biology Stands Out

Gynaecological cancers, particularly ovarian cancer, remain challenging due to late diagnosis, limited effective targeted therapies, and barriers that restrict conventional antibody-based treatments in solid tumours. Nanobodies—small, highly stable antibody fragments derived from camelids—offer superior tissue penetration, easier engineering, and potential for both diagnostic imaging and therapeutic delivery (theranostics).

This project asks a critical question: can engineered nanobodies overcome the biological and physical barriers that currently limit antibody therapies? Led by Professor Deya Gonzalez (Swansea University), an expert in translational gynaecological oncology and advanced therapeutic development, alongside Professor Lewis Francis (Swansea University) and Professor Chih-Chi Andrew Hu (Houston Methodist Research Institute), a leader in nanobody engineering, cancer biology, and molecular therapeutics, the research is designed for real-world impact.

See More Posts in Jobs, Scholarships, Technology, Career/Motivations, Football News Feeds

Join Job Whatsapp Channel, Scholarship Whatsapp Channel, Tech Whatsapp Channel, Follow Our Twitter (X) Channel.

Successful candidates will gain exceptional interdisciplinary training across translational oncology, molecular and cellular biology, cancer immunology, biotherapeutics, protein engineering, genomics, imaging, and preclinical models. You will have opportunities to publish in leading international journals, present at major conferences, and contribute to the development of next-generation theranostic technologies.

Project Structure and Research Focus

The programme is structured as a full-time collaborative PhD with time spent at both institutions:

First 15 months at Swansea University (Singleton Campus): Identify and validate clinically relevant ovarian cancer surface antigens. Work with patient-derived clinical samples, tumour slices, advanced three-dimensional tumour models, and integrated genomic analyses.
Remaining 21 months at Houston Methodist Research Institute: Focus on nanobody discovery and engineering, functional epitope mapping, tumour–immune interactions, and evaluation of novel nanobody-based imaging and therapeutic strategies in immune-competent preclinical ovarian cancer models.

This dual-site experience places you within world-class research environments and provides exposure to both academic and clinical translational settings. Start dates are October 2026 or January 2027. In exceptional circumstances, a single deferral of up to three calendar months may be considered at the discretion of the University and funding body, though this is not guaranteed.

Eligibility Criteria for the Fully Funded International PhD Cancer Biology Scholarship

The scholarship is open to UK and international applicants. Academic requirements are rigorous:

A 1st class UK undergraduate degree (or equivalent international qualification), or
A 2:1 UK undergraduate degree plus a Distinction in a UK master’s degree (or international equivalent).

English language requirements: IELTS 6.5 overall with no individual component below 6.5, or a Swansea University recognised equivalent. Certificate validity and accepted alternatives are detailed in the university’s English Language policy.

Some applicants may need ATAS clearance depending on nationality and research area; this is not required at the application stage. Successful candidates will receive guidance if applicable. For questions on academic or fee eligibility, contact pgrscholarships@swansea.ac.uk and include the scholarship web link.

Funding and Benefits of This Fully Funded PhD Scholarship in Cancer Biology UK

This Swansea University-funded scholarship provides comprehensive support:

Full coverage of tuition fees (UK and international rates)
Annual stipend at the UKRI rate of £21,805 for 2026/27 (from October 2026 onwards)
Additional research expenses of up to £500 per year

The funding enables focus on research without financial pressure and supports the international mobility between Swansea and Houston. Living in Swansea offers a high quality of life with coastal access, while the Houston placement immerses you in a major US medical research hub.

Click Here to See other Scholarships.

Get Standard CV and Scholarship Essay/Statement of Purpose/Motivation Letter from a Professional.

How to Apply for the Nanobody PhD Scholarship (RS982)

Applications must be submitted online via the Swansea University postgraduate research application portal. Follow these precise steps carefully, as incomplete applications will not be considered for the award:

Complete the full application form.
In the “Programme Related Information” section, enter the RS Code: RS982.
In the “Research” section:
- Enter the RS Code (RS982) and the full scholarship title in “Proposed project title/studentship title”.
- Leave the Proposed Supervisor and Research Project fields blank.
- Select “Yes” for “Do you have a proposal to upload?” and upload a PDF copy of the advert (print the page to PDF).
In “Funding information”, select only “Scholarship Funding”.

Required supporting documents (upload all via the online system; do not email them):

Curriculum Vitae (CV)
Degree certificates and transcripts (or screenshots of current grades if still studying)
Cover letter including a Supplementary Personal Statement explaining why the position matches your skills and experience and how you would develop the project
One academic or previous employer reference on headed paper or the official Swansea University reference form (private email accounts such as Hotmail are not accepted)
Evidence of English language proficiency (if applicable; offers can be conditional)
Copy of UK resident visa (if applicable)
Confirmation of Equality, Diversity and Inclusion (EDI) Monitoring Form submission (mandatory for PhD applicants)

Applications may be submitted in Welsh and will be treated equally. Only one application is permitted per individual Swansea University-led research scholarship; do not list multiple awards. If you have previously applied for the same programme, do not re-apply with a different email address. Contact pgrscholarships@swansea.ac.uk with your student number and the RS code for any necessary start-date adjustments.

Informal enquiries are welcome and can be directed to Professor Deya Gonzalez. Note that application data may be shared with external partners as part of the selection process for jointly relevant projects.

Official scholarship page and full details: https://www.swansea.ac.uk/postgraduate/scholarships/research/biomedical-sciences-cancer-biology-su-phd-rs982.php Application portal guidance and related postgraduate research information are available via Swansea University’s postgraduate research pages. English language requirements: https://www.swansea.ac.uk/admissions/english-language-requirements/. ATAS information: https://www.gov.uk/guidance/academic-technology-approval-scheme.

Preparing a Strong Application

Competition for fully funded PhD scholarships in cancer biology is high. Strengthen your application by:

Clearly linking your previous research experience, technical skills (cell culture, molecular biology, immunology, protein work, or related techniques), and career goals to the project’s focus on antigen validation, nanobody engineering, and theranostics.
Demonstrating understanding of the challenges in solid tumour targeting and the advantages of nanobodies.
Showing motivation for the dual UK–US training experience and collaborative environment.
Ensuring all documents are complete, accurate, and submitted well before the 17 August 2026 deadline.

Highlight any relevant laboratory experience with patient samples, 3D models, genomics, or antibody/nanobody-related work. A thoughtful Supplementary Personal Statement is essential.

Career Impact and Long-Term Opportunities

Completing this PhD positions graduates for careers in academic research, biotechnology, pharmaceutical development of biotherapeutics, translational oncology, or clinical research organisations. The combination of protein engineering expertise, cancer immunology insight, preclinical model experience, and international collaboration is highly valued. Access to publication and conference opportunities further builds a competitive research profile.

Swansea University’s Faculty of Medicine, Health and Life Science provides a supportive research environment, while the Houston Methodist placement offers exposure to advanced clinical and translational facilities. Together they create a powerful platform for impactful science.

Final Thought

This fully funded PhD scholarship in cancer biology UK represents a rare chance to work on high-impact nanobody research for gynaecological cancers within a prestigious UK–US partnership. With full financial support, dual-location training, and expert supervision, it is designed for outstanding candidates ready to push the boundaries of precision oncology.

Review the official advert carefully, prepare your documents thoroughly, and submit your application by 17 August 2026. For the most accurate and up-to-date information, always refer to the Swansea University scholarship page linked above. Questions about eligibility or the process can be directed to pgrscholarships@swansea.ac.uk.

Take the next step in your research career and help shape the future of theranostic approaches for patients with ovarian and other gynaecological cancers.

See More Posts In:

Tech School Info

Commonwealth Masters Scholarships 2027: How to Secure a Fully Funded UK Master’s Degree and Transform Your Future